Working Group Meeting, September 30 – October 1, 2008 Agenda

 

Talaris Conference Center, Seattle, WA

View Meeting Summary

This meeting will be in CLOSED session on Tuesday, September 30th.
Please note that the OPEN session for this meeting will be on
Wednesday, October 1st from 8:00 am to 2:00pm

Monday, September 30
Time Activity Speaker
8:30 – 9:30 EGAPP Working Group Subcommittee Breakout Sessions
  • Methods
  • Topics
  • Products
Steve Teutsch
Joan Scott
Celia Kaye
9:30 – 9:45 Welcome and Opening Statement Al Berg
9:45 – 10:15 Recap on EGAPP Working Group Retreat held September 29, 2008 Al Berg
10:15 – 10:30 Break
10:30 – 11:00 EGAPP Staff updates Dave Dotson
11:00 – 12:00 Status Report: Use of Genomic Profiling to Assess Risk for Cardiovascular Disease and Identify Individualized Prevention Strategies Glenn Palomaki &
Cecile Janssens
12:00 – 1:30

12:30 – 1:00

1:00 – 1:30

Working Lunch
  • Institute of Medicine (IOM) Roundtable on Translating  Genomic-based Research
  • Secretary’s Advisory Committee on Genetics, Health and Society (SACGHS)
Wylie Burke, Chair, IOM

Steve Teutsch, Chair, SACGHS

1:30 – 3:00 Breakout Session 1:  Use of Genomic Profiling to Assess Risk for Cardiovascular Disease and Identify Individualized Prevention Strategies
Breakout Session 2:  Methodology Development and Updating of Evidence Reports and Recommendations
Work Group Members & Consultants

Work Group Members & Consultants

3:00 – 3:15 Break
3:15 – 4:00 Breakout Session 1 Report and Discussion Work Group Members & Consultants
4:00 – 4:45 Breakout Session 2 Report and Discussion Work Group Members & Consultants
4:45 – 5:00 Wrap-up and Adjourn Closed Session Al Berg

 

Tuesday, October 1
Time Activity Speaker
7:30 – 8:00 Breakfast for Working Group in Meeting Room
8:00 – 8:30 Overview of Day 1, brief staff updates and outstanding questions Al Berg & Staff
8:30 – 9:00 Topics Subcommittee Report Joan Scott
9:00 – 9:30 Planning for Future Topics Discussion Working Group Members and Consultants
9:30 – 10:00 Status Review: Multigene testing to assess risk of Type II Diabetes   Working Group  Members and Consultants
10:00 – 10:15

10:15 – 10:30

Public Comment

EGAPP Stakeholders Group Meeting Report

Debra Leonard, ESG Chair
10:30 – 10:45 Break and Checkout
10:45 – 11:15 Methods Subcommittee Report Steve Teutsch
11:15 – 11:45 Products Subcommittee Report Celia Kaye
11:45 – 12:00 Pick Up Lunch
12:00 – 1:00 Lunch
1:00 – 2:00 Wrap-up and Action Items Al Berg
2:00 Adjourn